Icad Stock Executives

ICAD
 Stock
  

USD 2.37  0.49  26.06%   

Icad employes about 136 people. The company is managed by 18 executives with total tenure of roughly 148 years, averaging almost 8.0 years of service per executive having 7.56 employees per reported executive. Evaluation of Icad management performance can provide insight into the firm performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Icad Inc future performance.
Please see Risk vs Return Analysis.
  
  Kenneth Ferry  CEO
CEO and Director
  Lawrence Howard  Chairman
Chairman of the Board
  Kevin Burns  President
President, CFO, COO, Treasurer and Secretary

Icad Management Team Effectiveness

Icad Inc has return on total asset (ROA) of (11.84) % which means that it has lost $11.84 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (27.08) %, meaning that it created substantial loss on money invested by shareholders. Icad management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Icad Workforce Comparison

Icad Inc is currently regarded as number one stock in number of employees category among related companies. The total workforce of Medical Devices industry is currently estimated at about 168,136. Icad adds roughly 136 in number of employees claiming only tiny portion of all equities under Medical Devices industry.

Icad Profit Margins

The company has Profit Margin (PM) of (40.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (39.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.39.

Icad Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Icad insiders, such as employees or executives, is commonly permitted as long as it does not rely on Icad's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Icad insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Icad Inc Benchmark Summation

Operator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Icad Inc Price Series Subtraction is a subtraction of Icad price series from its benchmark/peer..
.

Icad Notable Stakeholders

An Icad stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Icad often face trade-offs trying to please all of them. Icad's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Icad's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kenneth Ferry - CEO and DirectorProfile
Lawrence Howard - Chairman of the BoardProfile
Kevin Burns - President, CFO, COO, Treasurer and SecretaryProfile
Scott Areglado - Vice President ControllerProfile
Richard Christopher - CFO, Executive Vice PresidentProfile
Jonathan Go - Sr. VP of RandDProfile
Stacey Stevens - Sr. VP of Marketing and StrategyProfile
Elliot Sussman - Independent DirectorProfile
Andrew Sassine - DirectorProfile
Somu Subramaniam - Independent DirectorProfile
Rakesh Patel - DirectorProfile
Steven Rappaport - Independent DirectorProfile
Michael Klein - DirectorProfile
Anthony Ecock - Independent DirectorProfile
Rachel Brem - Independent DirectorProfile
Susan Wood - DirectorProfile
Robert Goodman - DirectorProfile
Zack Kubow - IR Contact OfficerProfile

About Icad Management Performance

The success or failure of an entity such as Icad Inc often depends on how effective the management is. Icad management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Icad management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Icad management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.
The data published in Icad's official financial statements usually reflect Icad's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Icad Inc. For example, before you start analyzing numbers published by Icad accountants, it's critical to develop an understanding of what Icad's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Icad's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Icad's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Icad's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Icad Inc. Please utilize our Beneish M Score to check the likelihood of Icad's management to manipulate its earnings.

Icad Workforce Analysis

Traditionally, organizations such as Icad use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Icad within its industry.

Icad Manpower Efficiency

Return on Icad Manpower

Revenue Per Employee239.1 K
Revenue Per Executive1.8 M
Net Loss Per Employee96.7 K
Net Loss Per Executive730.6 K
Working Capital Per Employee99.2 K
Working Capital Per Executive749.3 K
Please see Risk vs Return Analysis. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.